-
Mashup Score: 11Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 2 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 2 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 2 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 2 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 3 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 3 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 3 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Virtual Symposium - Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023 - 3 month(s) ago
Current and Future Perspectives for Bispecific Antibodies in Multiple Myeloma: Learnings from 2023
Source: multiplemyelomahub-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Virtual Symposium - Holistic pain management in multiple myeloma - 2 year(s) ago
Holistic pain management in multiple myeloma
Source: multiplemyelomahub-cme.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Virtual Symposium - Holistic pain management in multiple myeloma - 2 year(s) ago
Holistic pain management in multiple myeloma
Source: multiplemyelomahub-cme.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Up to 90% of patients with #multiplemyeloma develop osteolytic bone lesions, one of the most common complications, and >75% of these experience back pain. Find out how you can help patients with bone lesions during our live symposium. https://t.co/IpqnOtoL2y #cancerpain #mmsm https://t.co/8fljm2KRfv
-
Up to 90% of patients with #multiplemyeloma develop osteolytic bone lesions, one of the most common complications, and >75% of these experience back pain. Find out how you can help patients with bone lesions during our live symposium. https://t.co/IpqnOtoL2y #cancerpain #mmsm https://t.co/MvjLrvsTUa
-
Join our live symposium on the current and future perspectives for bispecific antibodies in #MultipleMyeloma: Learnings from 2023 Chaired by @SagarLonialMD 📅 Date: March 11, 2024 🕔 Time: 8:00 – 9:30AM EST https://t.co/ssGw1g9y7l #bispecific #myeloma #mmsm https://t.co/h8OMhaHt34